D. Le - Concepedia

Author

D. Le

University of California San Diego ORCID

Also Known As

D T Le, D. Le, D.T. LE, D.T. Le, DT Le, Dinh T. P. Le, Dionne Le

Publications

470

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Scripps Research Institute

About

D. Le is an author at University of California San Diego specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	375
2	Natural Sciences	2	2	184
3	Cell Biology	2	2	184
4	Allergy	1	1	82
5	Biochemistry	1	1	131

D. Le

Publications

442

Citations

H-Index

Page 1

	Year	Citations
Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. D. Le, Samuel I. Rapaport, L. Vijaya Mohan Rao Journal of Biological Chemistry Proteinlipid InteractionCell AdhesionTotal Viia TfCellular PhysiologyReactive Nitrogen Specie	1992	131
A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice. T Olee, S S Pierangeli, Harold H. Handley, Proceedings of the National Academy of Sciences ImmunologyPathologyAntiphospholipid AntibodiesHyperlipidemiaThrombosis	1996	82
Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers Luis A. Díaz, Aurélien Marabelle, T.W. Kim, Annals of Oncology OncologyKeynote-158 StudiesMedicineImmunologyPathology	2017	65
A phenotype survey of 36 mutant mouse strains with gene-targeted defects in glycosyltransferases or glycan-binding proteins Sally L. Orr, D. Le, Jeffrey M. Long, Glycobiology Phenotype SurveyGeneticsGlycobiologyImmunologyMolecular Biology	2012	53
Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant D. Le, JS Greengard, Vibhas S. Mujumdar, Blood	1995	49
Preliminary results of a phase II study: PD-1 blockade in mismatch repair–deficient, recurrent or persistent endometrial cancer A. Nickles Fader, Luis A. Díaz, D. K. Armstrong, Gynecologic Oncology Pd-1 BlockadeMedicineGynecologyPreliminary ResultsImmune Checkpoint Inhibitor	2016	44
A Protac®-based screening test for activated protein C-resistant factor Va and other defects of the protein C anticoagulant pathway Paige Gable, D. Le, William McGehee, Blood Coagulation & Fibrinolysis	1997	18

Page 1